Katherine Isoardi

1.1k total citations
79 papers, 602 citations indexed

About

Katherine Isoardi is a scholar working on Emergency Medicine, Toxicology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Katherine Isoardi has authored 79 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Emergency Medicine, 15 papers in Toxicology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Katherine Isoardi's work include Poisoning and overdose treatments (42 papers), Forensic Toxicology and Drug Analysis (14 papers) and Opioid Use Disorder Treatment (13 papers). Katherine Isoardi is often cited by papers focused on Poisoning and overdose treatments (42 papers), Forensic Toxicology and Drug Analysis (14 papers) and Opioid Use Disorder Treatment (13 papers). Katherine Isoardi collaborates with scholars based in Australia, United Kingdom and United States. Katherine Isoardi's co-authors include Keith Harris, Geoffrey K. Isbister, Colin B. Page, Nicholas A. Buckley, Angela L. Chiew, Betty S. Chan, Stephen Rashford, Anselm Wong, Adam C. Pomerleau and David Reith and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Katherine Isoardi

66 papers receiving 584 citations

Peers

Katherine Isoardi
Brandon K. Wills United States
Daniel C. Keyes United States
Frank F S Daly Australia
Cathleen Clancy United States
Mark B. Mycyk United States
Jay L. Schauben United States
Mark E. Sutter United States
Timothy J. Wiegand United States
Kenneth D. Katz United States
Brandon K. Wills United States
Katherine Isoardi
Citations per year, relative to Katherine Isoardi Katherine Isoardi (= 1×) peers Brandon K. Wills

Countries citing papers authored by Katherine Isoardi

Since Specialization
Citations

This map shows the geographic impact of Katherine Isoardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Isoardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Isoardi more than expected).

Fields of papers citing papers by Katherine Isoardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Isoardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Isoardi. The network helps show where Katherine Isoardi may publish in the future.

Co-authorship network of co-authors of Katherine Isoardi

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Isoardi. A scholar is included among the top collaborators of Katherine Isoardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Isoardi. Katherine Isoardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isbister, Geoffrey K., Angela L. Chiew, Nicholas A. Buckley, et al.. (2025). A non-inferiority randomised controlled trial of a shorter acetylcysteine regimen for paracetamol overdose – the SARPO trial. Journal of Hepatology. 83(4). 881–887.
2.
Isoardi, Katherine, Sam Alfred, Courtney Weber, et al.. (2025). Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems. Drug and Alcohol Review. 45(1). e13998–e13998. 9 indexed citations
3.
Chan, Betty S., et al.. (2025). Management of hypotension in dihydropyridine calcium channel blocker overdose: The role of high‐dose insulin therapy. British Journal of Clinical Pharmacology. 91(9). 2613–2620. 2 indexed citations
4.
Smith, Jennifer L., Courtney Weber, Jennifer Schumann, et al.. (2025). Novel psychoactive substances in Australian emergency departments: implications for public health practice from multi-centre prospective toxicosurveillance across five states, 2022–2023. International Journal of Drug Policy. 145. 104969–104969.
5.
Isbister, Geoffrey K., et al.. (2024). Calcium channel blocker overdose: Not all the same toxicity. British Journal of Clinical Pharmacology. 91(3). 740–747. 4 indexed citations
6.
Chiew, Angela L., et al.. (2024). Rivastigmine for the management of anticholinergic delirium. Clinical Toxicology. 62(2). 82–87. 6 indexed citations
7.
Berling, Ingrid, et al.. (2024). Growing burden of gamma‐hydroxybutyrate intoxication on emergency department resource utilisation. Emergency Medicine Australasia. 36(5). 792–794. 2 indexed citations
8.
Chiew, Angela L., Geoffrey K. Isbister, Katherine Isoardi, et al.. (2023). Acetaminophen Metabolites on Presentation Following an Acute Acetaminophen Overdose (ATOM‐7). Clinical Pharmacology & Therapeutics. 113(6). 1304–1314. 8 indexed citations
9.
Isoardi, Katherine, et al.. (2023). Intubation for patients with overdose: Time to move on from the Glasgow Coma Scale. Emergency Medicine Australasia. 35(4). 702–705. 5 indexed citations
10.
Downes, Michael A., et al.. (2022). Case series profile of olanzapine post‐injection delirium/sedation syndrome. British Journal of Clinical Pharmacology. 89(2). 903–907. 6 indexed citations
11.
Chan, Betty S., Katherine R. Allen, Ingrid Berling, et al.. (2022). Tapentadol exposures and poisonings in Australia. Clinical Toxicology. 60(9). 1063–1066. 4 indexed citations
12.
Smith, Jennifer L., Andrew Dawson, Sam Alfred, et al.. (2021). The Emerging Drugs Network of Australia: A toxicosurveillance system of illicit and emerging drugs in the emergency department. Emergency Medicine Australasia. 34(1). 58–64. 26 indexed citations
13.
Chan, Betty S., Geoffrey K. Isbister, Angela L. Chiew, Katherine Isoardi, & Nicholas A. Buckley. (2021). Clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. (ATOM-6). Clinical Toxicology. 60(4). 433–439. 12 indexed citations
14.
Buckley, Nicholas A., Katherine Isoardi, Geoffrey K. Isbister, et al.. (2021). Optimising alkalinisation and its effect on QRS narrowing in tricyclic antidepressant poisoning. British Journal of Clinical Pharmacology. 88(2). 723–733. 4 indexed citations
15.
Buckley, Nicholas A., Katherine Isoardi, Angela L. Chiew, et al.. (2020). Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning. Clinical Toxicology. 59(6). 464–471. 14 indexed citations
16.
Buckley, Nicholas A., Sonia Cheng, Katherine Isoardi, et al.. (2020). Haemodialysis for lithium poisoning: Translating EXTRIP recommendations into practical guidelines. British Journal of Clinical Pharmacology. 86(5). 999–1006. 10 indexed citations
17.
Chan, Betty S., Shaokoon Cheng, Katherine Isoardi, et al.. (2020). Effect of age on the severity of chronic lithium poisoning. Clinical Toxicology. 58(11). 1023–1027. 7 indexed citations
18.
Isoardi, Katherine, et al.. (2019). Neurotoxicity in chronic lithium poisoning. Internal Medicine Journal. 50(4). 427–432. 7 indexed citations
19.
Isoardi, Katherine, et al.. (2018). Methamphetamine presentations to an emergency department: Management and complications. Emergency Medicine Australasia. 31(4). 593–599. 41 indexed citations
20.
Chan, Betty S., Geoffrey K. Isbister, Colin B. Page, et al.. (2018). Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4). Clinical Toxicology. 57(7). 638–643. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026